Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, December 14, 2016 ) This report provides comprehensive information on the therapeutic development for Dyslipidemia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule...
Source: EmailWire.com
(Medical-NewsWire.com, December 14, 2016 ) This report provides comprehensive information on the therapeutic development for Prader-Willi Syndrome (PWS), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration...
Source: EmailWire.com
(Medical-NewsWire.com, December 14, 2016 ) This report provides comprehensive information on the therapeutic development for Pyelonephritis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and...
Source: EmailWire.com
(Medical-NewsWire.com, December 14, 2016 ) This report provides comprehensive information on the therapeutic development for High Triglyceridemia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA)...
Source: EmailWire.com
(Medical-NewsWire.com, December 14, 2016 ) This report provides comprehensive information on the therapeutic development for Birch Pollen Allergy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA)...
Source: EmailWire.com
(Medical-NewsWire.com, December 14, 2016 ) This report provides comprehensive information on the therapeutic development for Elephantiasis (Lymphatic Filariasis), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration...
Source: EmailWire.com
(Medical-NewsWire.com, December 14, 2016 ) Publisher Drug Report, "Fazlodeks- Drug Insights, 2016" highlights the Fazlodeks marketed details, pipeline status and the Global API Manufacturers along with the location. The Publisher's report covers the Global Market Assessment of the Fazlodeks covering...
Source: EmailWire.com
(Medical-NewsWire.com, December 14, 2016 ) Publisher's, "Fatty Acid Synthesis Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Fatty Acid Synthesis Inhibitors. The Publisher's Report covers the product profiles...
Source: EmailWire.com
(Medical-NewsWire.com, December 14, 2016 ) DelveInsight's, " Familial Hypercholesterolemia (Type II Hyperlipoproteinemia)-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Familial Hypercholesterolemia (Type II Hyperlipoproteinemia)....
Source: EmailWire.com
(Medical-NewsWire.com, December 14, 2016 ) Publisher's, "Factor IX A Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Factor IX A Inhibitors. The Publisher's Report covers the product profiles in various stages...
Source: EmailWire.com
(Medical-NewsWire.com, December 14, 2016 ) Publisher's, "Factor IIa (Thrombin) Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Factor IIa (Thrombin) Inhibitors. The Publisher's Report covers the product profiles...
Source: EmailWire.com
(Medical-NewsWire.com, December 14, 2016 ) Publisher Drug Report, "Eviplera- Drug Insights, 2016" highlights the Eviplera marketed details, pipeline status and the Global API Manufacturers along with the location. The Publisher's report covers the Global Market Assessment of the Eviplera covering...
Source: EmailWire.com
(Medical-NewsWire.com, December 14, 2016 ) DelveInsight's Report, "Esophagitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016", provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key...
Source: EmailWire.com
(Medical-NewsWire.com, December 14, 2016 ) DelveInsight's, " Esophageal Cancer-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Esophageal Cancer. The DelveInsight'sReport covers the product profiles in various stages of...
Source: EmailWire.com
(Medical-NewsWire.com, December 14, 2016 ) DelveInsight's Esophageal Cancer -Market Insights, Epidemiology and Market Forecast-2023" Reports provides an overview of the disease and global market trends of the Crohn's disease for the seven major markets ie: United States, EU5 (France, Germany, Italy,...
Source: EmailWire.com
|
|
|
|